Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Low‑Burden Follicular Lymphoma: Rituximab Versus Bispecifics
Matt and Sonali debate treating low‑volume FL, emphasizing not overtreating and pending trials comparing mosunetuzumab to rituximab.
Play episode from 57:19
Transcript
